» Articles » PMID: 34812139

BRAF Induces Reversible Mitotic Arrest in Human Melanocytes Via Microrna-mediated Suppression of AURKB

Abstract

Benign melanocytic nevi frequently emerge when an acquired mutation triggers unchecked proliferation and subsequent arrest in melanocytes. Recent observations have challenged the role of oncogene-induced senescence in melanocytic nevus formation, necessitating investigations into alternative mechanisms for the establishment and maintenance of proliferation arrest in nevi. We compared the transcriptomes of melanocytes from healthy human skin, nevi, and melanomas arising from nevi and identified a set of microRNAs as highly expressed nevus-enriched transcripts. Two of these microRNAs-MIR211-5p and MIR328-3p-induced mitotic failure, genome duplication, and proliferation arrest in human melanocytes through convergent targeting of AURKB. We demonstrate that induces a similar proliferation arrest in primary human melanocytes that is both reversible and conditional. Specifically, expression stimulates either arrest or proliferation depending on the differentiation state of the melanocyte. We report genome duplication in human melanocytic nevi, reciprocal expression of AURKB and microRNAs in nevi and melanomas, and rescue of arrested human nevus cells with AURKB expression. Taken together, our data describe an alternative molecular mechanism for melanocytic nevus formation that is congruent with both experimental and clinical observations.

Citing Articles

Identification of Oncogene-Induced Senescence-Associated MicroRNAs.

Foutadakis S, Soureas K, Roupakia E, Besta S, Avgeris M, Kolettas E Methods Mol Biol. 2025; 2906:189-213.

PMID: 40082357 DOI: 10.1007/978-1-0716-4426-3_11.


Transcriptional reprogramming triggered by neonatal UV radiation or Lkb1 loss prevents BRAF-induced growth arrest in melanocytes.

McGrail K, Granado-Martinez P, Orsenigo R, Caratu G, Nieto P, Heyn H Oncogene. 2025; .

PMID: 40057604 DOI: 10.1038/s41388-025-03339-7.


Transdermal Delivery of Ultradeformable Cationic Liposomes Complexed with miR211-5p (UCL-211) Stabilizes BRAFV600E+ Melanocytic Nevi.

Chhibber T, Scherzer M, Prokofyeva A, Becker C, Zitnay R, Smith E bioRxiv. 2024; .

PMID: 39484595 PMC: 11527197. DOI: 10.1101/2024.10.17.618694.


Dangerous liaisons: Loss of keratinocyte control over melanocytes in melanomagenesis.

Green K, Pokorny J, Jarrell B Bioessays. 2024; 46(11):e2400135.

PMID: 39233509 PMC: 11626500. DOI: 10.1002/bies.202400135.


Quantitative phase imaging based on holography: trends and new perspectives.

Huang Z, Cao L Light Sci Appl. 2024; 13(1):145.

PMID: 38937443 PMC: 11211409. DOI: 10.1038/s41377-024-01453-x.


References
1.
Clark A, Karasic T, DeMichele A, Vaughn D, OHara M, Perini R . Palbociclib (PD0332991)-a Selective and Potent Cyclin-Dependent Kinase Inhibitor: A Review of Pharmacodynamics and Clinical Development. JAMA Oncol. 2015; 2(2):253-60. DOI: 10.1001/jamaoncol.2015.4701. View

2.
King R, Hayzen B, Page R, Googe P, Zeagler D, Mihm Jr M . Recurrent nevus phenomenon: a clinicopathologic study of 357 cases and histologic comparison with melanoma with regression. Mod Pathol. 2009; 22(5):611-7. DOI: 10.1038/modpathol.2009.22. View

3.
Hejna M, Jorapur A, Song J, Judson R . High accuracy label-free classification of single-cell kinetic states from holographic cytometry of human melanoma cells. Sci Rep. 2017; 7(1):11943. PMC: 5607248. DOI: 10.1038/s41598-017-12165-1. View

4.
Chu E, Wanat K, Miller C, Amaravadi R, Fecher L, Brose M . Diverse cutaneous side effects associated with BRAF inhibitor therapy: a clinicopathologic study. J Am Acad Dermatol. 2012; 67(6):1265-72. PMC: 4838029. DOI: 10.1016/j.jaad.2012.04.008. View

5.
Cohen P, Bedikian A, Kim K . Appearance of New Vemurafenib-associated Melanocytic Nevi on Normal-appearing Skin: Case Series and a Review of Changing or New Pigmented Lesions in Patients with Metastatic Malignant Melanoma After Initiating Treatment with Vemurafenib. J Clin Aesthet Dermatol. 2013; 6(5):27-37. PMC: 3662681. View